Infant, Premature Clinical Trial
— CCotOfficial title:
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Verified date | October 2021 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will determine whether the efficacy of Mylar-lined cardboard cots is equivalent to traditional incubators in their ability to prevent hypothermia (axillary temperature < 36° C) in preterm neonates <36 6/7 weeks gestational age in a randomized cross-over designed trial. Infants will be randomized to receive care in the cardboard cot or incubator and then cross over to the other device for 24 hour periods, rotating for a total of 96 hours total trial time.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 27, 2021 |
Est. primary completion date | September 27, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 5 Days |
Eligibility | Inclusion Criteria: - Estimated gestational age < 36 6/7 weeks - Hospitalized in the NICU at University Teaching Hospital in Zambia - Requiring incubator/radiant warmer for at least 1 week Exclusion Criteria: - Abdominal wall defect or myelomeningocele - Major congenital anomalies - Blistering skin disorder - Suspected Sepsis - Requiring ongoing respiratory support |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Moderate (32.-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature | Temperature taken via axilla for 1 minute duration | 1 hour after placement in warming device | |
Primary | Moderate (32.0-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature | Temperature taken via axilla for 1 minute duration | 6 hours after placement in warming device | |
Primary | Moderate (32.-35.9° C) or Severe (<32.0°C) hypothermia per Axillary Temperature | Temperature taken via axilla for 1 minute duration | 24 hours after placement in warming device | |
Secondary | Normothermia (Axillary temperature 36.0 - 38.0° C) | Temperature taken via axilla for 1 minute duration | 1-96 hours after beginning of study | |
Secondary | Hypothermia (Axillary temperature < 36.0° C) | Temperature taken via axilla for 1 minute duration | 1-96 hours after beginning of study | |
Secondary | Mean Axillary Temperature in each device | Average of all axillary temperatures taken per device | 4 months | |
Secondary | Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 1 hour after placement in warming device | |
Secondary | Rate of Moderate hypothermia (32.0-35.9°C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 6 hours after placement in warming device | |
Secondary | Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 24 hours after placement in warming device | |
Secondary | Rate of Severe hypothermia (<32.0° C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 1 hour after placemnt in warming device | |
Secondary | Rate of Severe hypothermia (<32.0° C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 6 hours after placement in warming device | |
Secondary | Rate of Severe hypothermia (<32.0° C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 24 hours after placement in warming device | |
Secondary | Rate of Hyperthermia (>38.0°C) after placement in warming device | Temperature taken via axilla for 1 minute duration | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03146351 -
The Effects of Family Centered Intervention Program on Preterm Infants
|
N/A | |
Completed |
NCT02064712 -
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
|
N/A | |
Completed |
NCT00365703 -
Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?
|
N/A | |
Terminated |
NCT00179933 -
The Impact of Implementing NIDCAP on Preterm Infants in the NICU
|
N/A | |
Completed |
NCT00114543 -
Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
|
Phase 3 | |
Terminated |
NCT05030012 -
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
|
N/A | |
Completed |
NCT00552383 -
The Edmonton Randomised Controlled Trial of NIDCAP - Based Developmental Care
|
N/A | |
Completed |
NCT00011362 -
Dexamethasone Therapy in VLBW Infants at Risk of CLD
|
Phase 3 | |
Completed |
NCT06308471 -
Effect of Baby Massage on Oral Motor Skills of Premature Babies
|
N/A | |
Completed |
NCT01863043 -
Aspiration of Residual Gastric Contents
|
N/A | |
Completed |
NCT05462509 -
Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda
|
N/A | |
Not yet recruiting |
NCT06109350 -
The Effect of Physical Therapy Intervention on Motor Performance in Bhutanese Preterm Infants
|
N/A | |
Terminated |
NCT02599545 -
Testosterone and Cortisol Levels in Infants
|
||
Completed |
NCT03551600 -
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
|
||
Completed |
NCT02611284 -
Less Invasive Beractant Administration in Preterm Infants
|
N/A | |
Completed |
NCT01193270 -
Vitamin E for Extremely Preterm Infants
|
Phase 1 | |
Completed |
NCT00455169 -
Influenza Vaccine in Premature Infants
|
Phase 4 | |
Withdrawn |
NCT00536445 -
Use of NAVA in Intubated Preterm
|
Phase 1/Phase 2 | |
Completed |
NCT00579553 -
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
|
N/A | |
Completed |
NCT01203423 -
Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study
|